← Eichor
Study identifier: NCT07665424 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety and Efficacy Clinical Trial of the Vessel-X® Bone Filling Container System

Condition: Osteoporosis · Osteoporotic Vertebral Compression Fractures  ·  Sponsor: Juin-Hong Cherng

PhaseNA
Planned participants146
Who can joinAll sexes, 40 Years to 95 Years
Healthy volunteersNo

About this study

Osteoporotic vertebral compression fractures (OVCFs) are a common and serious complication of osteoporosis, particularly among elderly and postmenopausal patients. OVCFs may result in severe pain, functional impairment, spinal deformity, and reduced quality of life. Conventional conservative treatments, including bed rest, analgesics, and bracing, may provide limited symptom relief. Minimally invasive vertebral augmentation procedures, such as vertebroplasty and kyphoplasty, have been widely used to improve clinical outcomes; however, risks including bone cement leakage and incomplete vertebral restoration remain concerns. The Vessel-X® Bone Filling Container System, manufactured by Central Medical Technologies Inc. (CMT), is a third-generation vesselplasty technology designed for percutaneous vertebral augmentation procedures. The system utilizes an implantable biocompatible polyethylene terephthalate (PET) container with a microporous structure for controlled bone cement delivery. The implant remains within the vertebral body after cement injection and is designed to reduce cement leakage while maintaining vertebral height restoration and pain relief. This post-market clinical study evaluates the safety and clinical effectiveness of the Vessel-X® Bone Filling Container System at two medical centers in Taiwan with a total target enrollment of 146 subjects: Tri-Service General Hospital (TSGH): 86 subjects randomized in a 1:1 ratio to the experimental and control groups. T…

This description comes directly from the study's public registry record.

Talk to the study team

Juin-Hong Cherng, Ph.D.  ·  886-2-87923100  ·  i72bbb@gmail.com

Gang-Yi Fan, Ph.D.  ·  886-2-87923100  ·  u9310318@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Tri-Service General Hospital, National Defense Medical UnivesityTaipei, TaiwanRecruiting
National Defense Medical University, TaiwanTaipei, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07665424